ABSTRACT
ABSTRACT: We report on a congenital tumor of the face and scalp in a male newborn, histologically proven to contain melanocytes, cartilage, and bone, vascular, and neural tissue as part of a pigmented congenital tumor. Thus, this tumor was classified as a cutaneous cephalic neurocristic hamartoma.
Subject(s)
Facial Neoplasms/pathology , Hamartoma/pathology , Head and Neck Neoplasms/pathology , Neural Crest/pathology , Scalp/pathology , Skin Neoplasms/pathology , Blood Vessels/pathology , Bone and Bones/pathology , Cartilage/pathology , Facial Neoplasms/congenital , Hamartoma/congenital , Head and Neck Neoplasms/congenital , Humans , Infant, Newborn , Male , Melanocytes/pathology , Nerve Tissue/pathology , Skin Neoplasms/congenital , Tumor BurdenSubject(s)
Anodontia , Hair Diseases , Tooth Abnormalities , Anodontia/diagnostic imaging , Hair , Hair Diseases/diagnosis , HumansABSTRACT
INTRODUCTION: Felix Pinkus' concept of the vitreous membrane (VM) published in 1927 describes circular folds protruding into the outer root sheath (ORS), which, in his opinion, serve as interdigitations between the outer root sheath (ORS) and the VM. This concept currently seems to have fallen into oblivion. OBJECTIVE: To determine the origin and possible function of the VM in the proliferation and vascularization of the hair follicle (HF). METHODS: Serial investigation of healthy skin probes with histological (hematoxylin & eosin and periodic acid-Schiff) and immunohistochemical examination (Ki67, CD56, CD8, and collagen IV) were performed. RESULTS: Morphological variations of the VM in various HFs such as protrusions and folds, the latter unilateral, bilateral or circular, some acute-angled, were found. Similarly, protrusions of the VM into the ORS were observed, that consisted of capillary tissue together with perifollicular tissue and VM mimicking minimal variants of the dermal papilla. CONCLUSIONS: Pinkus' concept of the VM is revisited, reproduced and possible functions are proposed. Since these structures are found in a HF region with a high metabolic dynamism, they may be involved in differentiation or nutrition, or else be formed as a result of pressure arising from outgrowing hair shafts.
ABSTRACT
Ichthyoses are a group of rare genetic skin disorders that pose numerous clinical challenges, in particular with respect to the correct diagnosis and appropriate management. The present update of the German ichthyosis guidelines addresses recent diagnostic advances that have resulted in the Sorèze consensus classification. In this context, we provide an updated diagnostic algorithm, taking into account clinical features as well as the molecular genetic basis of these disorders. Moreover, we highlight current therapeutic approaches such as psychosocial support, balneotherapy, mechanical scale removal, topical therapy, and systemic retinoid therapy. General aspects such as the indication for physical therapy, ergotherapy, or genetic counseling are also discussed. The present update was consented by an interdisciplinary consensus conference that included dermatologists, pediatricians, human geneticists, and natural scientists as well as representatives of the German patient support organization Selbsthilfe Ichthyose e. V.
Subject(s)
Guideline Adherence , Ichthyosis/diagnosis , Ichthyosis/therapy , Adolescent , Adult , Child , Child, Preschool , Diagnosis, Differential , Female , Genetic Predisposition to Disease/genetics , Germany , Humans , Ichthyosis/classification , Ichthyosis/genetics , Infant , Infant, Newborn , Male , Pregnancy , Prognosis , Young AdultSubject(s)
Infliximab/therapeutic use , Melkersson-Rosenthal Syndrome/drug therapy , Child , Crohn Disease/diagnosis , Crohn Disease/drug therapy , Diagnosis, Differential , Dose-Response Relationship, Drug , Drug Administration Schedule , Humans , Infliximab/adverse effects , Infusions, Intravenous , Male , Melkersson-Rosenthal Syndrome/diagnosis , Off-Label Use , Treatment OutcomeSubject(s)
Acrodermatitis/diagnosis , Facial Dermatoses/diagnosis , Skin/pathology , Zinc/deficiency , Diagnosis, Differential , Female , Humans , InfantABSTRACT
Twenty-six families with keratinopathic ichthyoses (epidermolytic ichthyosis, superficial epidermolytic ichthyosis or congenital reticular ichthyosiform erythroderma) were studied. Epidermolytic ichthyosis is caused by mutations in the genes KRT1 or KRT10, mutations in the gene KRT2 lead to superficial epidermolytic ichthyosis, and congenital reticular ichthyosiform erythroderma is caused by frameshift mutations in the genes KRT10 or KRT1, which lead to the phenomenon of revertant mosaicism. In this study mutations were found in KRT1, KRT2 and KRT10, including 8 mutations that are novel pathogenic variants. We report here the first case of a patient with congenital reticular ichthyosiform erythroderma carrying a mutation in KRT10 that does not lead to an arginine-rich reading frame. Novel clinical features found in patients with congenital reticular ichthyosiform erythroderma are described, such as mental retardation, spasticity, facial dysmorphisms, symblepharon and malposition of the 4th toe.
Subject(s)
Hyperkeratosis, Epidermolytic/genetics , Ichthyosis, Lamellar/genetics , Keratin-10/genetics , Keratin-1/genetics , Keratin-2/genetics , Mutation , Adolescent , Adult , Aged , Child , Child, Preschool , DNA Mutational Analysis , Female , Genetic Association Studies , Genetic Predisposition to Disease , Heredity , Humans , Hyperkeratosis, Epidermolytic/diagnosis , Ichthyosis, Lamellar/diagnosis , Infant , Infant, Newborn , Male , Middle Aged , Pedigree , Phenotype , Risk Factors , Severity of Illness Index , Young AdultSubject(s)
Osteomyelitis/complications , Osteomyelitis/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antirheumatic Agents/therapeutic use , Arthralgia/etiology , Child , Female , Humans , Magnetic Resonance Imaging , Methotrexate/therapeutic use , Muscular Atrophy/etiology , Naproxen/therapeutic use , Paronychia/etiology , Psoriasis/etiologyABSTRACT
Variations in hair shaft morphology reflect ethnical diversity, but may also indicate internal diseases, nutritional deficiency, or hair and scalp disorders. The measurement and the follow-up of the hair shaft thickness over a defined period of time would be a valuable diagnostic tool in clinical practice. Standard light microscopy (LM) measurements require the epilation of hair shafts and frequently yield inaccurate values caused by the elliptic geometry of human hair shafts. Optical coherence tomography (OCT) is a noninvasive investigation method based on the principles of Michelson interferometry with a detection depth of approximately 1 mm in human skin. Two-dimensional images of the cross sections of tissue samples at a resolution of approximately 10 µm are produced, which allows convenient calculation of hair shaft thickness. To evaluate this new methodology for hair shaft thickness measurements, hair shafts taken from 28 healthy volunteers were analyzed by in vivo OCT and compared to standard in vitro LM measurements of hair shaft thickness. OCT yielded highly reproducible measurements of hair shaft thickness with a distinctly reduced variation compared to standard LM. This technique offers a unique opportunity for in vivo measurement and a follow-up of the kinetics of hair shaft thickness in humans during medical therapy.
Subject(s)
Hair/anatomy & histology , Image Processing, Computer-Assisted/methods , Tomography, Optical Coherence/methods , Adult , Female , Humans , Middle Aged , Reproducibility of ResultsABSTRACT
Albright hereditary osteodystrophy with pseudohypoparathyroidism is due to maternal loss-of-function mutations in the GNAS gene. Its typical clinical features encompass obesity, a round face and a short neck, osteoma of the skin, endocrinological abnormalities, and psychomotoric retardation. Here we present a 10-month-old Tunisian boy with a classical course of this rare disease.
Subject(s)
Hyperpigmentation/pathology , Pseudohypoparathyroidism/pathology , Fibrous Dysplasia, Polyostotic/genetics , Fibrous Dysplasia, Polyostotic/pathology , Humans , Hyperpigmentation/genetics , Infant , Male , Pseudohypoparathyroidism/genetics , Skin/pathologyABSTRACT
Focal facial dermal dysplasia (FFDD) (OMIM 227260) is a rare ectodermal disorder characterized by congenital bitemporal scar-like depressions resembling forceps marks and variable additional facial manifestations. No gene defects or gene loci for FFDD are known to date. We report on a large multi-generational German family with typical characteristics of FFDD and provide a detailed clinical description of four affected individuals. They had large bitemporal discolored dermal depressions, sparse lateral eyebrows, abnormal eyelashes, and dysplastic and low-set ears. Three of the four affected individuals had congenital horizontal nystagmus, which had hitherto only been reported in a single patient with FFDD. In contrast to previous assumptions about an autosomal recessive etiology of this disorder, this family provides further evidence that FFDD is inherited in an autosomal dominant mode. Although this family is not large enough to yield significant results in linkage analysis, it may, in combination with other families, contribute to the identification of a gene locus for this intriguing ectodermal disorder.
Subject(s)
Ectodermal Dysplasia/genetics , Focal Dermal Hypoplasia/genetics , Abnormalities, Multiple/genetics , Abnormalities, Multiple/pathology , Adult , Child, Preschool , Ear, External/abnormalities , Ectodermal Dysplasia/pathology , Eyebrows/abnormalities , Eyelashes/abnormalities , Eyelids/abnormalities , Face , Female , Focal Dermal Hypoplasia/pathology , Genes, Dominant , Germany , Humans , Male , Middle Aged , Nystagmus, Congenital/genetics , Pedigree , SyndromeSubject(s)
Brain Diseases/complications , Ectodermal Dysplasia/complications , Lipomatosis/complications , Neurocutaneous Syndromes/complications , Nevus/complications , Skin Neoplasms/complications , Brain Diseases/diagnosis , Ectodermal Dysplasia/pathology , Humans , Infant, Newborn , Lipomatosis/diagnosis , Magnetic Resonance Imaging , Male , Neurocutaneous Syndromes/diagnosis , Nevus/pathology , Rare Diseases , Skin Neoplasms/pathologyABSTRACT
Although conventional vaccines have generated major successes in the control of infectious diseases, several obstacles remain in their development against chronic diseases (HIV, tuberculosis), against which no current candidate vaccines yet ensure protection. The transcutaneous route of vaccine administration appears to be a promising approach of targeting vaccines toward antigen-presenting cells (APCs) and thus improving immune responses. We investigated the suitability of nanoparticles in this approach. We found a high density of Langerhans cells (LCs) around hair follicles that, when sorted, readily internalized all size particles. However, flow cytometry after transcutaneous application of 40, 750, or 1,500 nm nanoparticles on human skin samples revealed that only 40 nm particles entered epidermal LC. Fluorescence and laser scan microscopies, which were carried out to identify the penetration pathway of transcutaneously applied nanoparticles, revealed that only 40 nm particles deeply penetrate into vellus hair openings and through the follicular epithelium. We conclude that 40 nm nanoparticles, but not 750 or 1,500 nm nanoparticles, may be efficiently used to transcutaneously deliver vaccine compounds via the hair follicle into cutaneous APCs.
Subject(s)
Hair Follicle/metabolism , Langerhans Cells/metabolism , Nanostructures , Skin Absorption , Administration, Cutaneous , Antigens, CD1/analysis , Bacterial Vaccines/administration & dosage , Epidermal Cells , Epidermis/immunology , Epidermis/metabolism , Hair Follicle/cytology , Hair Follicle/immunology , Humans , Langerhans Cells/immunology , Particle Size , Skin/cytology , Skin/immunology , Skin/metabolism , Viral Vaccines/administration & dosageABSTRACT
Proopiomelanocortin (POMC)-derived peptides and their receptors have been identified in many peripheral organs including the skin in which they exert a diversity of biological actions. We investigated the expression and potential role of the POMC system in human dermal papilla cells (DPCs), a specialized cutaneous mesenchymal cell type regulating hair follicle activity. In culture, these cells expressed POMC and displayed immunoreactivity for ACTH, alphaMSH, and beta-endorphin. Among the prohormone convertases (PCs) tested, only PC2, its chaperone 7B2, and furin convertase but not PC1 and paired basic amino acid cleaving enzyme 4 gene were detected. Human DPCs in vitro expressed both the melanocortin-1 receptor (MC-1R) and MC-4R, and immunoreactivity for these receptors was also present in cells of the human dermal papilla in situ. In contrast to the dermal papilla of agouti mice, agouti signaling protein, a natural and highly selective MC-1R and MC-4R antagonist, was undetectable in human DPCs. The MC-Rs detected in human DPCs were functionally active because alphaMSH increased intracellular cAMP and calcium. Preincubation of the cells with a synthetic peptide corresponding to the C-terminal domain of agouti signaling protein abrogated cAMP induction by alphaMSH. Furthermore, alphaMSH was capable of antagonizing the expression of intercellular adhesion molecule-1 induced by the proinflammatory cytokine interferon-gamma. Our data suggest a regulatory function of alphaMSH within the dermal papilla whose disruption may lead to deregulation of immune and inflammatory responses of the hair follicle, thereby possibly contributing to the development of inflammatory forms of alopecia.
Subject(s)
Dermis/immunology , Immune System/physiology , Receptor, Melanocortin, Type 1/metabolism , Receptor, Melanocortin, Type 4/metabolism , alpha-MSH/physiology , Adrenocorticotropic Hormone/metabolism , Agouti Signaling Protein , Cells, Cultured , Fluorescent Antibody Technique , Furin/metabolism , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/metabolism , Neuroendocrine Secretory Protein 7B2/metabolism , Pro-Opiomelanocortin/metabolism , Proprotein Convertase 2/metabolism , beta-Endorphin/metabolismABSTRACT
Protein biochips have a great potential in future parallel processing of complex samples as a research tool and in diagnostics. For the generation of protein biochips, highly automated technologies have been developed for cDNA expression library production, high throughput protein expression, large scale analysis of proteins, and protein microarray generation. Using this technology, we present here a strategy to identify potential autoantigens involved in the pathogenesis of alopecia areata, an often chronic disease leading to the rapid loss of scalp hair. Only little is known about the putative autoantigen(s) involved in this process. By combining protein microarray technology with the use of large cDNA expression libraries, we profiled the autoantibody repertoire of sera from alopecia areata patients against a human protein array consisting of 37,200 redundant, recombinant human proteins. The data sets obtained from incubations with patient sera were compared with control sera from clinically healthy persons and to background incubations with anti-human IgG antibodies. From these results, a smaller protein subset was generated and subjected to qualitative and quantitative validation on highly sensitive protein microarrays to identify novel alopecia areata-associated autoantigens. Eight autoantigens were identified by protein chip technology and were successfully confirmed by Western blot analysis. These autoantigens were arrayed on protein microarrays to generate a disease-associated protein chip. To confirm the specificity of the results obtained, sera from patients with psoriasis or hand and foot eczema as well as skin allergy were additionally examined on the disease-associated protein chip. By using alopecia areata as a model for an autoimmune disease, our investigations show that the protein microarray technology has potential for the identification and evaluation of autoantigens as well as in diagnosis such as to differentiate alopecia areata from other skin diseases.